Implementation of MenB Vaccine Recommendations in Older Adolescents & Young Adults Living in Central Texas
The overall goal of this education and quality improvement project is to improve vaccination rates among adolescents and young adults against meningococcal B disease by implementing the current Category A and B Centers for Disease Control (CDC) and Prevention, Advisory Committee on Immunization Practices (ACIP) recommendations for serogroup B meningococcal (MenB) vaccine. The target audience is individuals aged ≥10 years at high risk for meningococcal disease and those aged 16-23 years, their parents, the general public, and BSWH healthcare providers (doctors, physician extenders or advanced practice providers such as physician assistants, nurse practitioners, nurses, and support staff) in Pediatrics, Family Medicine, Gynecology, and Adolescent & College Health. We will accomplish this goal by improving provider education, initiating quality improvement projects within local primary care clinics, utilizing monthly reminders and provider incentives, partnering with local schools and colleges to increase public education, and utilizing our Electronic Health Record System (EHR) to encourage providers to actively offer the vaccine to adolescents and young adults at every clinic visit. At the clinic level, subject matter experts will utilize onsite presentations to educate BSWH primary health care professionals on how to recommend and effectively communicate the importance of this vaccine. Clinics will have sufficient product inventory to vaccinate all eligible adolescents with the MenB vaccine, and the project team will measure local data and improvements.
|Full Proposal||Interim Reports||Final Report|